WHO approved Johnson & Johnson’s single-dose vaccine – News

“Each new safe and effective instrument against Covid-19 is one more step towards controlling the pandemic,” commented WHO Director-General Tedros Adhanom Ghebreyesus.

Both of these vaccines require a double dose and Pfizer can only be stored at extremely cold temperatures.

/ Home of the embed code /

/ End of embed code /

Instead, drugs Janssen can be stored in a conventional refrigerator.

With this approval, the vaccine will be able to integrate the Covax program, founded by the WHO, the Alliance for Vaccines (GAVI) and the Coalition for Innovation in Epidemic Preparedness (CEPI), to distribute vaccines to developing countries. developing.

Today’s WHO decision is preceded by authorization from the European Medicines Agency (EMA), which was announced yesterday.

“The hope that these tools offer will only be realized if they are available to everyone in all countries. I urge governments and businesses to honor their commitments and use all the solutions at their disposal to increase production, so that these tools become true global public goods, available and affordable to all, ”said Ghebreyesus.

Janssen’s vaccine is the first to be listed by WHO as a single-dose regimen, which should facilitate the logistics of vaccination in all countries.

A press release from the same WHO points out that “extensive data from large clinical trials shared by the company also show that the vaccine is effective in older populations.”

To speed up vaccine registration, WHO and a team of reviewers from all regions have adopted what is called an “abbreviated assessment” based on the results of the EMA review and measurement of the vaccine. ‘efficiency of quality, safety and health data.

WHO will convene its Strategic Advisory Group of Immunization Experts next week to make recommendations on the use of the vaccine.

At the same time, the organization seeks to move forward with countries and Covax partners for the implementation and monitoring of the safety of this vaccine, for which the global alliance has reserved 500 million doses.